By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dicerna Pharmaceuticals 

480 Arsenal Street
Building 1, Suite 120
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-621-8097 Fax: n/a


Start Up

Company News
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4/1/2015 3:34:17 PM
Dicerna (DRNA) Announces Fourth Quarter And Full Year 2014 Financial And Operational Results 3/13/2015 9:50:55 AM
Dicerna (DRNA) To Announce Fourth Quarter And Full Year 2014 Financial Results And Host Conference Call On March 12, 2015 3/10/2015 11:12:05 AM
Booming Dicerna (DRNA) Takes a Larger Space in Cambridge and Plans to Hire 2/26/2015 6:06:14 AM
Dicerna Pharmaceuticals (DRNA) To Present At The 2015 Leerink Global Healthcare Conference 2/5/2015 11:19:16 AM
Dicerna Pharmaceuticals (DRNA) Announces First Patient Dosed In Phase 1b/2 Clinical Trial Of DCR-MYC, An Investigational Rnai Therapeutic Targeting The MYC Oncogene, In Patients With Advanced Hepatocellular Carcinoma 2/2/2015 10:44:45 AM
Dicerna Pharmaceuticals (DRNA) Presents Positive Preclinical Data On Its DsiRNA Therapeutics Targeting MYC And ?-Catenin At American Association for Cancer Research MYC: From Biology To Therapy Meeting 1/12/2015 12:53:51 PM
Dicerna Pharmaceuticals (DRNA) Announces Issuance Of US Patent Providing Broad Coverage Of DsiRNA-EX RNAi Payloads 1/12/2015 12:47:47 PM
Dicerna Pharmaceuticals (DRNA) Announces The Appointment Of Theodore T. Ashburn, M.D., Ph.D. To Senior Vice President, Product Strategy And Operations, And Inducement Grant Of Stock Options Under NASDAQ Listing Rule 5635 (C)(4) 12/18/2014 9:23:33 AM
Dicerna Pharmaceuticals (DRNA) R&D Update Webcast Reminder 12/15/2014 8:38:00 AM